NCT02376348

Brief Summary

Tanzania launched a National Strategy for scaling-up voluntary medical male circumcision in 2010, and aims to circumcise 2.8 million males by 2015. In September 2009, Jhpiego's Maternal and Child Health Integrated Program (MCHIP) launched a PEPFAR-funded voluntary medical male circumcision (VMMC) program which has circumcised over 110,000 males in Njombe and Iringa regions by June 2012. In line with the national strategy, the target age for the program was 10-34 years, but 80% of clients were aged 10-19 years. There is an urgent need to increase the proportion of older men (aged 20 years and above) who become circumcised, to have greatest impact on the HIV epidemic.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,782

participants targeted

Target at P75+ for not_applicable hiv

Timeline
Completed

Started Feb 2014

Typical duration for not_applicable hiv

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 3, 2014

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 24, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 3, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2015

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2017

Completed
Last Updated

October 6, 2017

Status Verified

October 1, 2017

Enrollment Period

1.2 years

First QC Date

February 24, 2015

Last Update Submit

October 5, 2017

Conditions

Keywords

VMMCAdult malesHIV PreventionAfrica

Outcome Measures

Primary Outcomes (1)

  • Impact of intervention on proportion of male clients aged 20-34 years (ratio of the geometric mean proportion of clients aged 20-34 years in the 10 intervention facilities versus that in the 10 control facilities)

    Cluster-level summary methods will be used to assess the impact of the intervention\[19\]. The primary outcome will be the unadjusted "prevalence ratio", estimated as the .

    5-6 weeks of demand creation activities

Secondary Outcomes (1)

  • Comparison of population attending for circumcision with general male population (proportion of males reporting the below risk factors will be compared to proportion of males reporting the same in the 2010 Tanzania Demographic and Health Survey)

    5-6 weeks

Study Arms (2)

Control

NO INTERVENTION

Individuals receiving the standard Ministry of Health Package

Intervention

EXPERIMENTAL

Individuals receiving the targeted demand creation strategy to increase adult men taking up VMMC

Behavioral: A targeted demand creation Activities

Interventions

Sites randomized to the intervention arm will receive all activities in the control arm, plus additional demand-creation communication messages that focus on the non-HIV benefits of VMMC and the voluntary nature of HIV testing prior to VMMC ii) use of already circumcised men from the community as auxiliary peer promoters, iii) separate waiting and group education areas for men aged 20 years and above during service delivery, iv) engagement of female partners in community-based demand creation and education and counselling about wound healing and post-circumcision abstinence.

Intervention

Eligibility Criteria

Age10 Years - 50 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Sites
  • an outreach VMMC health facility,
  • a site selected by Jhpiego for outreach VMMC campaign,
  • a site that has not had previous outreach services (to enable the results to be generalizable to future new outreach) or have not had VMMC outreach services in the previous 6 months, and
  • physically distant from other potential study sites to minimise contamination (spill over) of activities in the intervention communities into control communities.
  • The parent sites from different clusters must be at least 20km away from each other, regardless of whether they are randomised to be control or intervention sites.
  • Clients
  • Uncircumcised males
  • given an informed consent to participate in the study

You may not qualify if:

  • \) Circumcised males

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Njombe

Njombe, Tanzania

Location

Tabora

Tabora, Tanzania

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

February 24, 2015

First Posted

March 3, 2015

Study Start

February 3, 2014

Primary Completion

May 4, 2015

Study Completion

February 28, 2017

Last Updated

October 6, 2017

Record last verified: 2017-10

Locations